Cellular disease models are useful tools for Alzheimer's disease (AD) research. Pluripotent stem cells, including human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs), are promising materials for creating cellular models of such diseases. In the present study, we established cellular models of AD in hESCs that overexpressed the mutant Presenilin 1 (PS1) gene with the use of a sitespecific gene integration system. The overexpression of PS1 did not affect the undifferentiated status or the neural differentiation ability of the hESCs. We found increases in the ratios of amyloid-b 42 (Ab42)/ Ab40 and Ab43/Ab40. Furthermore, synaptic dysfunction was observed in a cellular model of AD that overexpressed mutant PS1. These results suggest that the AD phenotypes, in particular, the electrophysiological abnormality of the synapses in our AD models might be useful for AD research and drug discovery.
Introduction
Alzheimer's disease (AD) is one of the most common types of progressive dementia in the elderly population. It is characterized by some key features, including the deposition of amyloid beta (Ab) peptide plaques, the formation of neurofibrillary tangles and the loss of neurons [1, 2] . According to the amyloid cascade hypothesis, the extracellular accumulation of Ab peptides acts as a trigger for the onset of AD; this is followed by changes in the presynaptic proteins and the loss of synapses in the AD patient's brain [3e5].
Cognitive ability is thought to be dependent on the synapse function of the neurons [6] .
AD is classified into sporadic and familial types [7] . Presenilin 1 (PS1) is one of the genes responsible for familial AD [7, 8] . PS1 is a catalytic core of g-secretase and is produced from amyloid precursor protein by Ab species such as Ab40, Ab42 and Ab43 [9, 10] . Mutant PS1 transgenic mice show some of the phenotypes of AD, including an increased level of Ab42 and age-related neuronal loss [11, 12] .
In spite of the huge efforts of researchers, there are currently no fundamental therapeutic agents for AD. At present, pluripotent stem cells (PSCs) such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) are becoming promising materials for basic research and cell-based therapies. PSCs are selfrenewing cells which have the ability to differentiate into any type of cell in the human body. This ability has led to hPSC-derived cellular disease models which can be an unlimited source for numerous types of cells for disease research and pharmacological studies [13e15] .
One of methods generating cellular AD models is the use of iPSC technology. Several studies have reported the establishment of various AD patient-specific iPSC lines and AD phenotypes, in models of AD (reviewed in Ref. [16] ). However, models which replicate the electrophysiological abnormalities of synapses have not yet been reported. Moreover, it is difficult to accurately compare patient-specific iPSCs with healthy cells because of their different genomic backgrounds. Isogenic iPSC lines can be generated with the use of genome-editing methods [17, 18] . However, the creation of multiple isogenic iPSC lines with this technology is time-consuming and not cost-effective.
Recently, we developed a site-directed gene integration system [19] . Using this system, we have already established hESC lines which overexpress superoxide dismutase 1 (SOD1), a gene which is responsible for amyotrophic lateral sclerosis (ALS), and showed that our ALS models, which had different mutations, displayed different drug responses [20] . In this study, we established hESC lines which overexpressed mutant PS1 using the site-directed gene integration system to create cellular models of AD. We found that our AD models showed AD phonotypes, including synaptic dysfunction.
Material and methods

The culture of hESCs
The procedure for maintaining the KhES-1 and KhES-1-HS hESC lines was essentially the same as that which was previously described [19, 21] . The use of the hESC lines conformed to the Guidelines for Derivation and Utilization of Human Embryonic Stem Cells of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
The establishment of hESC lines which overexpressed mutant PS1 by the site-specific gene integration method
To establish hESC lines that overexpressed the PS1 gene, we utilized the KhES-1-HS hESC line, which was the parent cell line for the hypoxanthine phosphoribosyltransferase 1 (HPRT1) locus specific-gene integration system [19] . The expression vectors for wild-type and mutant PS1 cDNA (P117L, G378E, and D385A) were constructed. The resulting PS1 expression vectors were introduced into KhES-1-HS along with pEF1-Cre, as described in the previous paper [19] . Karyotype analyses of the PS1-overexpressing clones were carried out by Chromosome Science Lab, Inc. (Japan).
The neural differentiation of hESCs
Undifferentiated hESCs were cultured in N2B27 neural induction medium supplemented with both 100 ng/ml recombinant mouse noggin (R&D systems) or 100 nM LDN193189 (Cellagen Technology), and 1 mM SB431542 (SigmaeAldrich) on poly-L-lysine (PLL)/Laminin111 (LM)-coated culture dishes. After 7e10 days, the cell colonies were dissociated into cell clumps using collagenase (GIBCO) and cultured in N2B27 medium with noggin or LDN193189 alone for the following 7e10 days. The cell colonies were enzymatically dissociated into cell clumps again and cultured in N2B27 induction medium. After 5e6 days, the cells were dissociated into single cells by Accutase (Innovative Cell Technologies), and cultured in N2B27 supplemented with 10 ng/ml of brain-derived neurotrophic factor, 10 ng/ml of neurotrophin-3 and 100 ng/ml of nerve growth factor (all from NGF, R&D Systems) on PLL, LM and fibronectin-coated dishes for neural maturation. After 7 days, the cells were treated with 1 mM Cytosine b-D-arabinofuranoside (SigmaeAldrich).
Immunocytochemistry
The cells were fixed in freshly prepared 4% paraformaldehyde and permeabilized by 0.5% Triton-X (Wako Chemicals, Japan). The primary antibodies used in this study included polyclonal antibodies against NANOG (ReproCELL), bIII-tubulin (Abcam), or monoclonal antibodies against OCT3/4 (Santa Cruz Biotechnology), NeuN (Chemicon), SSEA4 (Chemicon), TRA1-60 (Chemicon). Alexa Fluor 488 and 568 goat anti-mouse immunoglobulin G, Alexa Fluor 488 goat anti-mouse immunoglobulin M, and Alexa Fluor 488 and 568 goat anti-rabbit IgG (Molecular Probes) were used as secondary antibodies. The cells were counterstained with 4,6-diamidino-2-phenylindole (DAPI) (SigmaeAldrich) for the visualization of all nuclei. Images were captured under fluorescence microscopy (Olympus, Japan) and analyzed using the ImageJ software program (NIH). The numbers of immunopositive cells were counted in four or five random areas. Approximately 1000 DAPI-stained cells were used to calculate the proportion of immunopositive cells.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted from undifferentiated hESCs using an RNeasy mini kit (Qiagen) according to the manufacturer's protocol. Total RNA was subjected to cDNA synthesis using the SuperScript III Reverse Transcriptase (Invitrogen). A semi-quantitative RT-PCR was carried out using the primers listed in Supplementary Table S1.
Immunoblotting
Protein extracts were prepared on ice in RIPA buffer (SigmaeAldrich) supplemented with a protease inhibitor cocktail (PIERCE). The protein concentration was determined using a BCA protein assay kit (PIERCE). The protein extracts were resolved on a 5e20% Tris-glycine acrylamide gel (Cosmobio, Japan) and transferred to a PVDF membrane (Bio-Rad) for immunoblotting. To detect PS1 proteins, a polyclonal antibody against the N-terminal region of the PS1 protein (Santa Cruz Biotechnology), horseradish peroxidase (HRP)-conjugated anti-rabbit IgG antibody (Cell Signaling Technology), an ECL Plus Western Blotting Detection System (GE Healthcare), and a LAS-3000 Bioimaging Analyzer System (Fuji Film, Japan) were used. b-actin, which was used as a loading control, was detected by a monoclonal antibody against bactin (Applied Biological Materials) and HRP-conjugated antimouse IgG antibody (Cell Signaling Technology).
The enzyme-linked immunosorbent assays (ELISAs) for the measurement of PS1 protein and amyloid beta expression levels
For the measurement of PS1 protein, PS1 was measured in the protein extracted from cells using a Human Presenilin-1 N-Term DuoSet ELISA Development kit (R&D Systems) according to the manufacturer's protocol. The amounts of Ab40, 42 and 43 in the culture media were measured using Human Amyloid b Assay Kits (IBL, Japan) according to the manufacturer's protocol. N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenyglycine t-butyl ester (DAPT) (Calbiochem) was used to inhibit g-secretase in the hESC-derived neurons. The IC50 values were calculated using a MasterPlex ReaderFit system (Hitachi Solutions, Japan).
Patch-clamp recordings
An electrophysiological analysis was performed using hESCderived neurons which were cultured for more than 2 weeks in a maturation culture stage. An HEKA EPC10 amplifier (HEKA Instruments Inc) was used for recording data in a whole cell patch clamp configuration. To measure the frequency of the spontaneous postsynaptic currents, an external solution (140 mM NaCl, 5 mM KCl, 10 mM HEPES, 2 mM CaCl 2 , 1 mM MgCl 2 , and 10 mM glucose) was adjusted to pH 7.2 with NaOH. A pipette solution (130 mM Kaspartate, 1 mM MgCl 2 , 10 mM EGTA, 3 mM ATP-Mg, and 10 mM HEPES) was adjusted to pH 7.2 with KOH. Neurons were voltageclamped at À60 mV or À30 mV to detect spontaneous excitatory postsynaptic currents (EPSCs) or spontaneous inhibitory postsynaptic currents (IPSCs), respectively. The inward and outward current events were recorded as sEPSCs and as sIPSCs, respectively, for 60 s.
Electron microscopy
The hESC-derived neurons on the cover slips (15 mm in diameter, Thermanox, Nunc) were chemically fixed with 2% glutaraldehyde in NaHCa buffer (100 mM NaCl, 30 mM HEPES, 2 mM CaCl 2 , adjusted at pH 7.4 with NaOH). The procedures that followed were performed as described in our previous paper [22] , with the exception that the post-fixed specimens were embedded in Epon812 resin (TAAB Laboratories Equipment Ltd, UK).
Results
The generation of PS1-overexpressing hESC lines
To establish hESCs that overexpressed wild-type or mutant PS1, we utilized the site-directing gene integration system that we developed in a previous study [19] . Using this system, an exogenous gene of interest can be inserted into the HPRT1 locus. As described in the Materials and Methods, the PS1 expression vectors (wildtype PS1, PS1eP117L, PS1-G378E or PS1-D385A) were introduced into the defined site of the genome. The PS1 protein expression level was examined to confirm the overexpression of exogenous PS1 (Fig. 1A) . The bands of the full-length PS1 were detected in all of the drug-resistant clones that we tested, while the full-length protein bands were not detected in the parent cell line KhES-1-HS. In a dominant-negative mutant PS1-D385A (PS1-D clones), Nterminal fragments of PS1 (which are generated by endoproteolysis) were not detected by immunoblotting. Because Aspartate 385 is important for endoproteolysis [23] , the PS1 proteins produced from the expression vectors were not self-digested. These data indicate that the PS1 proteins were overexpressed in these clones. Furthermore an ELISA showed the overexpression of PS1 in these clones (Fig. 1B) . The ELISA also indicated that the PS1 protein expression levels were almost the same among the clones that expressed wild-type or mutant PS1 genes. These data were expected because all of the clones had exogenous PS1 genes in the same site for gene integration and had an identical genetic background. On the other hand, the amount of N-terminal fragments of PS1 proteins appeared to be different (Fig. 1A) , suggesting that PS1 mutations might affect the efficiency of PS1 endoproteolysis.
An RT-PCR showed that PS1-overexpressing cells maintained the expression of the pluripotent-related genes and endogenous PS1, suggesting that PS1 overexpression did not affect the expression control of these pluripotent marker genes or the endogenous PS1 gene (Fig. 1C) . Next, we examined the expression of undifferentiated cell markers by immunocytochemistry (Fig. 1D) . All of the colonies expressed pluripotent markers, suggesting that PS1 overexpression did not affect the undifferentiated cell status. We also examined karyotyping. Although one clone (PS1eB2) had an abnormal karyotype, the other clones had normal karyotypes ( Supplementary Fig. S1 ). Taken together, these data indicated that PS1 overexpression did not affect chromosome stability and that the overexpression of PS1 did not affect undifferentiated status of hESCs. 
The neural differentiation of the PS1-overexpressing hESC lines
Single clones from wild-type or mutant PS1-overexpressing clones were used for further studies because there were no significant variations in the PS1 protein expression levels among any of the mutant-PS1 clones and because all of clones had an identical genetic background. First, we examined the neural differentiation ability of the PS1-overexpressing hESC lines. Neural markers, NeuN and bIII-tubulin were used to detect neurons derived from hESCs ( Fig. 2A) . The morphology of PS1-overexpressing neurons did not differ from the parental hESC-derived neurons. All of the cell lines showed a similar degree of neural differentiation efficiency, regardless of whether the hESC cells overexpressed the PS1 protein or not (Fig. 2B) . The overexpression of PS1 protein was confirmed in differentiated neurons (Fig. 2C) . Although the amount of full-length PS1 was decreased in comparison to undifferentiated cells, the Nterminal fragments of PS1 were clearly detected as thicker bands than in the parental hESC, HS. Electron microscopy demonstrated that synapses still formed as usual among these mutant PS1-expressing neurons (Fig. 2D) . Collectively, these data indicate that the overexpression of PS1 does not affect the ability of hESCs to differentiate into neurons.
Increases in Ab42 and Ab43 secretion from mutant PS1-expressing neurons
Increased Ab42 is a major characteristic of AD phenotypes. We measured the Ab42/Ab40 ratio in the culture medium of the hESCderived neurons by an ELISA (Fig. 3A) . The Ab42 ratio was clearly increased in mutant PS1-expressing neurons (PS1eB3 and PS1eC2), while the wild-type and the dominant-negative PS1-expressing neurons (PS1-A2 and PS1-D2) did not differ from the parent cells. We also found that the amount of Ab43, one of the Ab species, was clearly increased in PS1eC2 (G378E mutation) alone. These data are consistent with a previous report which indicated that the amount of Ab43 differed among PS1 mutant types [24] .
Next, we examined the reactivity of our AD models to a g-secretase inhibitor (DAPT). First, to accurately measure the IC50 values of DAPT in our AD models, we determined the culture period of the hESC-derived neurons. A three-week culture was not sufficient to perform an accurate IC50 measurement, but there was no significant difference between the 4-and 5-week cultures, which suggested that more than 4 weeks of culture was required to accurately determine the IC50 values of DAPT (Fig. 3C) . We then calculated the IC50 values of DAPT for wild-type and mutant PS1-expressing neurons using culture media that was cultivated for 4 weeks. There were no statistically significant differences among them (Fig. 3D) , indicating that the mutant PS1-overexpressing neurons show normal responsiveness to g-secretase inhibitors. In fact, our AD models responded to other known g-secretase inhibitors, such as BMS-708163 (Avagacestat), LY450139 (Semagacestat) and MK-0752 (data not shown). These data suggest the potential use of our AD models as tools for the AD drug screening system.
The alteration of the excitatory synapse activity of mutant PS1-expressing neurons
We next examined the electrophysiological features of our AD models to evaluate the functional alteration in neurons. Patch clamp analyses showed that there were no statistically significant differences in the action potential amplitude and frequency of PS1-expressing neurons (Fig. 4A and 4B) . However, we found that (PS1eB3 and PS1eC2) in comparison to wild-type PS1-expressing neurons (PS1-A2), while the frequency of spontaneous inhibitory postsynaptic current (sIPSC) was not altered (Fig. 4C and D) . These data suggested that PS1-overexpressing neurons could show synaptic alterations and that they may be useful as a cellular model of AD.
Discussion
In the present study, we established cellular models of AD which overexpressed mutant PS1 genes. We recently reported that the overexpression of mutant SOD1 was useful for showing ALS phenotypes [25] . These ALS models were established by a random integration method using mutant SOD1 cDNAs; hence the genetic expression of exogenous SOD1 was suppressed in some clones during neural differentiation [25] . However, this study showed that the expression of exogenous PS1 in the AD models was never silenced; although a slight reduction was observed in the hESCderived neurons -perhaps because of the property of the promoter used in the present study.
In addition, the expression levels of exogenous PS1 were almost the same among different clones with the same mutation. These results suggest that the use of a site-specific gene integration system enables a strict comparative analysis among the mutations in a gene of interest. We found that the ratio of Ab42/Ab40 or Ab43/ Ab40, and that the amount of PS1 fragment after self-proteolysis differed in 2 different PS1 mutations (P117L and. G378E), suggesting that these differences might reflect the properties of PS1 mutation. In addition, we recently reported that the ALS models generated by our gene integration method showed differential drug responses depending on the SOD1 mutations [20] . Thus, it is of interest whether different AD models show similarly mutationdependent drug responses.
Several papers have reported the usefulness of AD patientspecific iPS cells in AD research (reviewed in Ref. [16] ). However, these models did not show electrophysiological abnormalities. In contrast, our AD models showed synaptic dysfunction, indicating that our AD model has an advantage in the study of synaptic abnormalities using healthy and diseased cells with an identical genetic background. Future studies should address the cause of the synaptic abnormality in our AD models. Also, like the reduction of Ab production, the restoration of synaptic dysfunction in our AD models might be a useful indicator in discovering drugs to treat AD. In conclusion, our AD models which overexpress mutant PS1 are useful tools for AD research as well as AD patient-iPSC-derived models.
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